Cargando…

AB95. Epidemiology of post-transplant malignancy in Chinese renal transplant recipients

OBJECTIVE: To investigate the incidence and types of post-transplant malignancy in Chinese renal transplant recipients. METHODS: We searched the CNKI and the Wanfang Data Knowledge Service Platform using the keywords “renal transplantation” and “malignancy” in Chinese. Data from 3,462 patients who u...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jian, Ma, Linlin, Xie, Zelin, Guo, Yuwen, Sun, Wen, Zhang, Lei, Lin, Jun, Xiao, Jing, Zhu, Yichen, Tian, Ye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708347/
http://dx.doi.org/10.3978/j.issn.2223-4683.2014.s095
_version_ 1782409447807647744
author Zhang, Jian
Ma, Linlin
Xie, Zelin
Guo, Yuwen
Sun, Wen
Zhang, Lei
Lin, Jun
Xiao, Jing
Zhu, Yichen
Tian, Ye
author_facet Zhang, Jian
Ma, Linlin
Xie, Zelin
Guo, Yuwen
Sun, Wen
Zhang, Lei
Lin, Jun
Xiao, Jing
Zhu, Yichen
Tian, Ye
author_sort Zhang, Jian
collection PubMed
description OBJECTIVE: To investigate the incidence and types of post-transplant malignancy in Chinese renal transplant recipients. METHODS: We searched the CNKI and the Wanfang Data Knowledge Service Platform using the keywords “renal transplantation” and “malignancy” in Chinese. Data from 3,462 patients who underwent renal transplantation at Beijing Friendship Hospital were combined with data from 26 previous reports describing malignancy rates in 27,170 Chinese renal transplant recipients. RESULTS: The combined total of 30,632 patients underwent renal transplantation between 1974 and 2014, and 671 (2.19%) of these patients developed post-transplant malignancy. The most common sites of malignancy were the urinary system and digestive system. The ten most common malignancies were urothelial transitional cell carcinoma (n=283), hepatocellular carcinoma (n=68), gastrointestinal cancer (n=63), renal cell carcinoma (n=42), lymphoma (n=42), lung cancer (n=28), breast cancer (n=19), skin cancer (n=18), Kaposi’s sarcoma (n=12), and cervical cancer (n=10). Urinary system malignancy occurred in 252 patients in northern China and 87 patients in southern China. Digestive system malignancy occurred in 85 patients in southern China and 58 patients in northern China.
format Online
Article
Text
id pubmed-4708347
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-47083472016-01-26 AB95. Epidemiology of post-transplant malignancy in Chinese renal transplant recipients Zhang, Jian Ma, Linlin Xie, Zelin Guo, Yuwen Sun, Wen Zhang, Lei Lin, Jun Xiao, Jing Zhu, Yichen Tian, Ye Transl Androl Urol Abstract Publication Urology OBJECTIVE: To investigate the incidence and types of post-transplant malignancy in Chinese renal transplant recipients. METHODS: We searched the CNKI and the Wanfang Data Knowledge Service Platform using the keywords “renal transplantation” and “malignancy” in Chinese. Data from 3,462 patients who underwent renal transplantation at Beijing Friendship Hospital were combined with data from 26 previous reports describing malignancy rates in 27,170 Chinese renal transplant recipients. RESULTS: The combined total of 30,632 patients underwent renal transplantation between 1974 and 2014, and 671 (2.19%) of these patients developed post-transplant malignancy. The most common sites of malignancy were the urinary system and digestive system. The ten most common malignancies were urothelial transitional cell carcinoma (n=283), hepatocellular carcinoma (n=68), gastrointestinal cancer (n=63), renal cell carcinoma (n=42), lymphoma (n=42), lung cancer (n=28), breast cancer (n=19), skin cancer (n=18), Kaposi’s sarcoma (n=12), and cervical cancer (n=10). Urinary system malignancy occurred in 252 patients in northern China and 87 patients in southern China. Digestive system malignancy occurred in 85 patients in southern China and 58 patients in northern China. AME Publishing Company 2014-09 /pmc/articles/PMC4708347/ http://dx.doi.org/10.3978/j.issn.2223-4683.2014.s095 Text en 2014 Translational Andrology and Urology. All rights reserved.
spellingShingle Abstract Publication Urology
Zhang, Jian
Ma, Linlin
Xie, Zelin
Guo, Yuwen
Sun, Wen
Zhang, Lei
Lin, Jun
Xiao, Jing
Zhu, Yichen
Tian, Ye
AB95. Epidemiology of post-transplant malignancy in Chinese renal transplant recipients
title AB95. Epidemiology of post-transplant malignancy in Chinese renal transplant recipients
title_full AB95. Epidemiology of post-transplant malignancy in Chinese renal transplant recipients
title_fullStr AB95. Epidemiology of post-transplant malignancy in Chinese renal transplant recipients
title_full_unstemmed AB95. Epidemiology of post-transplant malignancy in Chinese renal transplant recipients
title_short AB95. Epidemiology of post-transplant malignancy in Chinese renal transplant recipients
title_sort ab95. epidemiology of post-transplant malignancy in chinese renal transplant recipients
topic Abstract Publication Urology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708347/
http://dx.doi.org/10.3978/j.issn.2223-4683.2014.s095
work_keys_str_mv AT zhangjian ab95epidemiologyofposttransplantmalignancyinchineserenaltransplantrecipients
AT malinlin ab95epidemiologyofposttransplantmalignancyinchineserenaltransplantrecipients
AT xiezelin ab95epidemiologyofposttransplantmalignancyinchineserenaltransplantrecipients
AT guoyuwen ab95epidemiologyofposttransplantmalignancyinchineserenaltransplantrecipients
AT sunwen ab95epidemiologyofposttransplantmalignancyinchineserenaltransplantrecipients
AT zhanglei ab95epidemiologyofposttransplantmalignancyinchineserenaltransplantrecipients
AT linjun ab95epidemiologyofposttransplantmalignancyinchineserenaltransplantrecipients
AT xiaojing ab95epidemiologyofposttransplantmalignancyinchineserenaltransplantrecipients
AT zhuyichen ab95epidemiologyofposttransplantmalignancyinchineserenaltransplantrecipients
AT tianye ab95epidemiologyofposttransplantmalignancyinchineserenaltransplantrecipients